After leading the transformation of Mylan into one of the world's largest global pharmaceutical companies, Robert J. Coury again led the company to another level by combining forces with Upjohn to form Viatris, a new champion for global health. His strategic vision and leadership guide the company's performance and growth.

Viatris Chief Executive Officer Michael Goettler is a proven leader, with nearly 25 years of pharmaceutical experience that crosses multiple therapeutic areas and all aspects of the business. He has a strong track record of running a global business with extensive commercial leadership. Goettler most recently served as group president of Pfizer’s Upjohn division and was a member of Pfizer’s Executive Leadership Team.

Rajiv Malik began his pharmaceuticals career as a scientist and went on to become a leading pharmaceutical industry executive with more than 60 process patents to his name. His deep commercial, scientific and operational experience is an invaluable asset in his role as president of Viatris.

Sanjeev Narula was appointed as the chief financial officer of Viatris following 16 years of experience in senior financial leadership positions at Pfizer. He has a deep understanding of financial and commercial dynamics across geographies and in all Viatris markets.